Xinglong Qu

698 total citations
28 papers, 516 citations indexed

About

Xinglong Qu is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Xinglong Qu has authored 28 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Infectious Diseases. Recurrent topics in Xinglong Qu's work include Cutaneous Melanoma Detection and Management (4 papers), Cancer-related molecular mechanisms research (3 papers) and Evolutionary Game Theory and Cooperation (3 papers). Xinglong Qu is often cited by papers focused on Cutaneous Melanoma Detection and Management (4 papers), Cancer-related molecular mechanisms research (3 papers) and Evolutionary Game Theory and Cooperation (3 papers). Xinglong Qu collaborates with scholars based in China, United States and Slovakia. Xinglong Qu's co-authors include Shucheng Hua, Ying Tang, Hongyu Jing, Huan Xia, Lingyun Liu, Zhigang Cao, Jianxin Guo, Xiaoguang Yang, Xianchun Tan and Baihe Gu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Cleaner Production.

In The Last Decade

Xinglong Qu

26 papers receiving 507 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xinglong Qu China 10 188 137 121 111 57 28 516
Jia Gu China 12 184 1.0× 136 1.0× 99 0.8× 116 1.0× 36 0.6× 33 428
Sandra Radenković Serbia 9 127 0.7× 114 0.8× 111 0.9× 127 1.1× 57 1.0× 17 453
Liangzhi Wen China 11 300 1.6× 124 0.9× 64 0.5× 95 0.9× 42 0.7× 26 521
Yan You China 12 243 1.3× 61 0.4× 160 1.3× 87 0.8× 62 1.1× 32 512
Fengjuan Lin China 11 277 1.5× 164 1.2× 105 0.9× 168 1.5× 53 0.9× 30 575
Patrycja Sosińska Poland 15 244 1.3× 87 0.6× 77 0.6× 127 1.1× 69 1.2× 29 564

Countries citing papers authored by Xinglong Qu

Since Specialization
Citations

This map shows the geographic impact of Xinglong Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinglong Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinglong Qu more than expected).

Fields of papers citing papers by Xinglong Qu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinglong Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinglong Qu. The network helps show where Xinglong Qu may publish in the future.

Co-authorship network of co-authors of Xinglong Qu

This figure shows the co-authorship network connecting the top 25 collaborators of Xinglong Qu. A scholar is included among the top collaborators of Xinglong Qu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinglong Qu. Xinglong Qu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yue, Chenxi Li, Tong Yin, et al.. (2025). Self-assembled epitope-based nanoparticles targeting the SARS-CoV-2 spike protein enhanced the immune response and induced potential broad neutralizing activity. Frontiers in Cellular and Infection Microbiology. 15. 1560330–1560330. 1 indexed citations
2.
Yu, Jinghua, Chunyu Liu, Xinglong Qu, Xinglin Gao, & Yue Liu. (2025). SERINC5 counters retroviruses and non-retroviruses. Frontiers in Cellular and Infection Microbiology. 14. 1516806–1516806.
3.
Qu, Xinglong, Ziyao Zhu, Xuehan Wu, et al.. (2025). KRT9 is required for GBP5 suppression of human respiratory syncytial virus. Journal of Virology. 99(2). e0202924–e0202924. 2 indexed citations
4.
Sun, Wei, Wending Huang, Wangjun Yan, et al.. (2023). Optimal timing of re‐excision in synovial sarcoma patients: Immediate intervention versus waiting for local recurrence. Journal of Surgical Oncology. 128(8). 1394–1406. 3 indexed citations
5.
Sun, Wei, et al.. (2023). Surgical resection margin for T3–T4 primary acral melanoma: a multicenter retrospective cohort study. Archives of Dermatological Research. 315(8). 2305–2312. 3 indexed citations
6.
Huan, Chen, Xinglong Qu, & Zhaolong Li. (2022). Host Restrictive Factors Are the Emerging Storm Troopers Against Enterovirus: A Mini-Review. Frontiers in Immunology. 13. 910780–910780. 4 indexed citations
7.
Guo, Jianxin & Xinglong Qu. (2021). Robust control in green production management. Journal of Industrial and Management Optimization. 18(2). 1115–1115. 1 indexed citations
8.
Hu, Tu, Wei Sun, Yu Xu, et al.. (2021). Combination of pembrolizumab plus temozolomide therapy in unresectable and advanced melanoma: a multicenter retrospective analysis in China. Annals of Translational Medicine. 9(21). 1625–1625. 13 indexed citations
9.
Li, Zhaolong, Xinglong Qu, Xin Liu, et al.. (2020). GBP5 Is an Interferon-Induced Inhibitor of Respiratory Syncytial Virus. Journal of Virology. 94(21). 35 indexed citations
10.
Wang, Haijiao, Xinglong Qu, Xiaoxia Liu, Lili Ding, & Ying Yue. (2019). Female Peritoneal Tuberculosis with Ascites, Pelvic Mass, or Elevated CA 125 Mimicking Advanced Ovarian Cancer: A Retrospective Study of 26 Cases. Journal of College of Physicians And Surgeons Pakistan. 29(6). 588–589. 14 indexed citations
11.
Guo, Jianxin, Xianchun Tan, Baihe Gu, & Xinglong Qu. (2019). The impacts of uncertainties on the carbon mitigation design: Perspective from abatement cost and emission rate. Journal of Cleaner Production. 232. 213–223. 20 indexed citations
12.
Chen, Yong, Wei Sun, Bing Wang, et al.. (2019). Apatinib for epithelioid sarcoma: analysis on eight advanced stage cases in a single institute.. Journal of Clinical Oncology. 37(15_suppl). e22551–e22551. 1 indexed citations
13.
Jing, Hongyu, Xinglong Qu, Lingyun Liu, & Huan Xia. (2018). A Novel Long Noncoding RNA (lncRNA), LL22NC03-N64E9.1, Promotes the Proliferation of Lung Cancer Cells and is a Potential Prognostic Molecular Biomarker for Lung Cancer. Medical Science Monitor. 24. 4317–4323. 44 indexed citations
14.
Qu, Xinglong, Ying Tang, & Shucheng Hua. (2018). Immunological Approaches Towards Cancer and Inflammation: A Cross Talk. Frontiers in Immunology. 9. 563–563. 240 indexed citations
15.
Wang, Bing, et al.. (2018). Identification of the potential prognostic genes of human melanoma. Journal of Cellular Physiology. 234(6). 9810–9815. 5 indexed citations
16.
Qu, Xinglong, et al.. (2018). HOTAIR promotes osteosarcoma development by sponging miR‐217 and targeting ZEB1. Journal of Cellular Physiology. 234(5). 6173–6181. 37 indexed citations
17.
Wang, Sisi, Jian Zhang, Liyan Sui, et al.. (2017). Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis. Scientific Reports. 7(1). 14982–14982. 17 indexed citations
18.
Wang, Bing, et al.. (2016). Clinical study of docetaxel plus S-1 as neoadjuvant therapy for advanced gastric cancer. Oncology and Translational Medicine. 2(2). 80–83. 1 indexed citations
19.
Cao, Zhigang, et al.. (2013). Fashion, Cooperation, and Social Interactions. PLoS ONE. 8(1). e49441–e49441. 18 indexed citations
20.
Qu, Xinglong, et al.. (2012). Surgical treatment for cutaneous malignant melanoma. Tumori. 32(9). 744–747.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jia Gu Breakdown of academic impact, for papers by Sandra Radenković Breakdown of academic impact, for papers by Liangzhi Wen Breakdown of academic impact, for papers by Yan You Breakdown of academic impact, for papers by Fengjuan Lin Breakdown of academic impact, for papers by Patrycja Sosińska
Rankless by CCL
2026